Roche Holding Ltd. (RHHBY) Given Consensus Recommendation of “Buy” by Brokerages
Roche Holding Ltd. (NASDAQ:RHHBY) has received a consensus broker rating score of 1.67 (Buy) from the three analysts that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating and two have assigned a strong buy rating to the company.
Analysts have set a 12-month consensus target price of $34.65 for the company, according to Zacks. Zacks has also assigned Roche Holding an industry rank of 208 out of 265 based on the ratings given to related companies.
Several research analysts have recently issued reports on RHHBY shares. Zacks Investment Research downgraded Roche Holding from a “hold” rating to a “sell” rating in a research note on Tuesday, September 6th. Citigroup Inc. reiterated a “buy” rating on shares of Roche Holding in a report on Wednesday, August 3rd.
Hedge funds have recently made changes to their positions in the stock. Eqis Capital Management Inc. boosted its stake in shares of Roche Holding by 4.1% in the third quarter. Eqis Capital Management Inc. now owns 11,650 shares of the company’s stock valued at $361,000 after buying an additional 464 shares during the last quarter. New England Research & Management Inc. bought a new stake in shares of Roche Holding during the third quarter valued at approximately $503,000. Genesee Valley Trust Co. boosted its stake in shares of Roche Holding by 1.6% in the third quarter. Genesee Valley Trust Co. now owns 16,891 shares of the company’s stock valued at $525,000 after buying an additional 271 shares during the last quarter. Sterling Capital Management LLC boosted its stake in shares of Roche Holding by 19.1% in the second quarter. Sterling Capital Management LLC now owns 19,085 shares of the company’s stock valued at $627,000 after buying an additional 3,056 shares during the last quarter. Finally, Wunderlich Capital Managemnt boosted its stake in shares of Roche Holding by 2.5% in the second quarter. Wunderlich Capital Managemnt now owns 40,510 shares of the company’s stock valued at $1,335,000 after buying an additional 977 shares during the last quarter.
Shares of Roche Holding (NASDAQ:RHHBY) opened at 29.46 on Friday. The firm has a market capitalization of $200.84 billion and a P/E ratio of 21.94. Roche Holding has a 12-month low of $29.33 and a 12-month high of $35.13. The stock has a 50 day moving average of $30.72 and a 200-day moving average of $31.58.
Roche Holding Company Profile
Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.